日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

BAY-8400: A Novel Potent and Selective DNA-PK Inhibitor which Shows Synergistic Efficacy in Combination with Targeted Alpha Therapies

BAY-8400:一种新型强效选择性 DNA-PK 抑制剂,与靶向 Alpha 疗法联合使用可发挥协同作用

Markus Berger, Lars Wortmann, Philipp Buchgraber, Ulrich Lücking, Sabine Zitzmann-Kolbe, Antje M Wengner, Benjamin Bader, Ulf Bömer, Hans Briem, Knut Eis, Hartmut Rehwinkel, Florian Bartels, Dieter Moosmayer, Uwe Eberspächer, Philip Lienau, Stefanie Hammer, Christoph A Schatz, Qiuwen Wang, Qi Wang, 

Discovery and Characterization of the Potent and Highly Selective 1,7-Naphthyridine-Based Inhibitors BAY-091 and BAY-297 of the Kinase PIP4K2A

发现并表征强效且高选择性的 1,7-萘啶类激酶 PIP4K2A 抑制剂 BAY-091 和 BAY-297

Lars Wortmann, Nico Bräuer, Simon J Holton, Horst Irlbacher, Jörg Weiske, Christian Lechner, Robin Meier, Jakob Karén, Catrine Berthold Siöberg, Vera Pütter, Clara D Christ, Antonius Ter Laak, Philip Lienau, Ralf Lesche, Barbara Nicke, Shing-Hu Cheung, Marcus Bauser, Andrea Haegebarth, Franz von Nus

Localized Inhibition of Protein Phosphatase 1 by NUAK1 Promotes Spliceosome Activity and Reveals a MYC-Sensitive Feedback Control of Transcription

NUAK1 对蛋白磷酸酶 1 的局部抑制促进了剪接体活性并揭示了 MYC 敏感的转录反馈控制

Giacomo Cossa, Isabelle Roeschert, Florian Prinz, Apoorva Baluapuri, Raphael Silveira Vidal, Christina Schülein-Völk, Yun-Chien Chang, Carsten Patrick Ade, Guido Mastrobuoni, Cyrille Girard, Lars Wortmann, Susanne Walz, Reinhard Lührmann, Stefan Kempa, Bernhard Kuster, Elmar Wolf, Dominik Mumberg, M